Skip to main content
. 2021 Oct 24;18(21):11156. doi: 10.3390/ijerph182111156

Table 5.

Competing-risks regression model of prostate cancer diagnosed in Mallorca between 2006 and 2011 before (Model 1) and after (Model 2) multiple imputation (m = 10).

Model 1
(Original Data Set)
n = 2013
Model 2
(Imputed Data Set)
n = 2728
Variables Subhazard Ratio CI 95% Subhazard Ratio CI 95%
Charlson index (ref. 0)
  Charlson = 1 0.80 0.59, 1.08 0.84 0.62, 1.13
  Charlson = 2 1.83 1.26, 2.66 1.58 1.11, 2.26
  Charlson >= 3 1.40 0.91, 2.13 0.94 0.57, 1.56
Risk (ref. medium)
  High risk 2.68 1.67, 4.31 2.90 1.78, 4.71
  Very high risk 17.53 11.08, 27.72 16.72 10.31, 27.09
Histology (ref. adenoc.)
  Unspecified 3.40 2.50, 4.61 4.78 3.55, 6.42
  Others 4.01 2.11, 7.59 2.42 1.12, 5.20
Treatment (ref. local)
  Systemic 37.49 20.54, 68.42 29.83 16.83, 52.88
  Mixed 10.60 5.16, 21.75 10.51 5.40, 20.46
  Observation/unspecified 53.18 28.23, 100.19 35.17 19.36, 63.87